To develop a nomogram for predicting side-specific extracapsular extension (ECE) for planning nerve-sparing radical prostatectomy.
Materials and Methods
We retrospectively analysed data from 561 patients who underwent robot-assisted radical prostatectomy between February 2014 and October 2015. To develop a side-specific predictive model, we considered the prostatic lobes separately. Four variables were included: prostate-specific antigen; highest ipsilateral biopsy Gleason grade; highest ipsilateral percentage core involvement; and ECE on multiparametric magnetic resonance imaging (mpMRI). A multivariable logistic regression analysis was fitted to predict side-specific ECE. A nomogram was built based on the coefficients of the logit function. Internal validation was performed using 'leave-one-out' cross-validation. Calibration was graphically investigated. The decision curve analysis was used to evaluate the net clinical benefit.
Results
The study population consisted of 829 side-specific cases, after excluding negative biopsy observations (n = 293). ECE was reported on mpMRI and final pathology in 115 (14%) and 142 (17.1%) cases, respectively. Among these, mpMRI was able to predict ECE correctly in 57 (40.1%) cases. All variables in the model except highest percentage core involvement were predictors of ECE (all P ≤ 0.006). All variables were considered for inclusion in the nomogram. After internal validation, the area under the curve was 82.11%. The model demonstrated excellent calibration and improved clinical risk prediction, especially when compared with relying on mpMRI prediction of ECE alone. When retrospectively applying the nomogramderived probability, using a 20% threshold for performing nerve-sparing, nine out of 14 positive surgical margins (PSMs) at the site of ECE resulted above the threshold.
Introduction
Extracapsular extension (ECE) in prostate cancer (PCa) affects both patient prognosis and surgical strategy [1, 2] . In the context of non-organ-confined PCa, ECE represents the per continuitatem extension of the tumour. Pre-surgical identification of ECE is of pivotal importance for the proper management of the disease [3, 4] . The presence of ECE has direct implications for surgical approach towards peri-capsular structures, especially the neurovascular bundles (NVBs) posterolaterally [5] . Inability to preserve the NVBs will negatively affect postoperative urinary continence and erectile function [6, 7] .
The greatest challenge a urologist faces is to balance the risk of ECE, which can affect positive surgical margin (PSM) status, with the benefit of performing robot-assisted nervesparing radical prostatectomy (NS-RARP), especially in young patients with a good erectile function. Current AUA guidelines recommend performing nerve-sparing radical prostatectomy (NSRP) in patients with localized disease [8] . The European Association of Urology guidelines recommend not to preserve the NVB in patients with clinical stage >T2c, and with any biopsy Gleason score >7 [9] .
Preoperative clinical staging based on DRE has limited accuracy, with understaging of ECE in 25-30% of cases [10, 11] . Several models have been proposed for the prediction of ECE in order to improve preoperative risk assessment [2, [12] [13] [14] [15] ; however, no models currently integrate sidespecific multiparametric MRI (mpMRI) findings and sidespecific biopsy data for the prediction of ECE. Because unilateral NSRP is often attempted by a urologist, insufficient side-specific ECE prediction poses challenges at the time of surgery and increases the possibility of both PSMs and/or unnecessary nerve excision.
In our centre, in order to tailor the best surgical strategy to each patient and optimize NS-RARP, we obtain preoperative staging mpMRI in the majority of patients [16] ; however, mpMRI has a sensitivity and specificity for ECE prediction ranging from 35% to 78% and 83% to 92%, respectively; this by itself is inadequate to guide the decision to perform NSRP [17] [18] [19] . Existing decision tools and nomograms fall short in answering this critical question and there is a need for a comprehensive and imaging-inclusive model that minimizes PSMs and maximizes the probability of NSRP.
The aim of the present study was to create an easy-to-apply model designed for the prediction of side-specific ECE in PCa, which integrates mpMRI prediction with clinical data, thus providing urologists with a guide for NSRP.
Materials and Methods

Study Population
After receiving institutional board approval, data from 589 patients who underwent robot-assisted radical prostatectomy between February 2014 and October 2015 were retrospectively collected. Patients who underwent neoadjuvant hormonal therapy or radiation therapy were excluded. We included patients who underwent mpMRI before surgery. All patients received a standard systematic (12-core) transrectal biopsy prior to surgery. When mpMRI was performed prior to biopsy, two to four extra targeted biopsy cores were obtained in addition to the standard 12 cores; this was done only when the mpMRI identified a lesion(s). Our technique for NS-RARP has been described previously [20, 21] . We use a graded approach to nerve-sparing (NS), which balances the competing goals of oncological safety and functional preservation. All external biopsy slides were re-read by an expert uro-pathologist at our centre (K.H.). Each surgery was performed by an experienced surgeon (A.T.). We excluded patients with missing data for analysis purposes: unknown PSA at surgery (n = 4); unavailable data concerning ECE at mpMRI (n = 11); and incomplete biopsy data (n = 13). The final analysis included 561 patients.
Outcome and Study Design
The outcome of the present study was the presence of documented ECE, defined as a breach of the pseudocapsule and direct extension of the prostatic carcinoma into the periprostatic tissue in at least one specific area on final pathology.
For analyses purposes, we considered the two lobes of the prostate separately, as previously described [12, 13, 22] . Because of our side-specific approach, biopsies that were negative on one side of the prostate were not considered in the ipsilateral analysis. Out of 561 patients, tumours were documented on the right lobe in 410 cases and on the left lobe in 419 cases. Finally, a total of 829 observations were considered for analysis purposes.
Variables Definition
Variables included in the model consisted of preoperative PSA (considered as continuous variable), Gleason biopsy grade (1 vs 2 vs 3 vs 4-5), maximum percentage of tumour in the biopsy core with the highest Gleason score (≤50% vs >50%) and documented definite ECE on mpMRI. Imaging features used to assess for ECE included NVB invasion or asymmetry, bulging of the prostatic contour, irregular or spiculated margins, obliteration of the recto-prostatic angle, broad-based tumour abutment of the pseudocapsule >1.0 cm, and breach of the pseudocapsule with evidence of direct tumour extension or bladder wall invasion as described in American College of Radiology Prostate Imaging and Reporting Data System (PI-RADS) v2 [23] . Because PI-RADS v2 does not specifically provide a scoring system to convey the probability of ECE at mpMRI, imaging reports documenting broad capsular contact, abutment or bulge without gross ECE were considered negative for ECE. Documented loss of prostate capsule and irregularity of the capsule was considered positive for ECE.
To develop a side-specific predictive model, variables included in the model were considered side-specific, meaning highest ipsilateral biopsy Gleason grade group (GGG) with corresponding highest percentage of core involvement, as well as documented ipsilateral ECE at mpMRI.
Multiparametric Prostate MRI
Our patients routinely undergo mpMRI, either prior to or at least 4 weeks after the prostate biopsy. Patients underwent mpMRI either at our institution (n = 341, 60.8%) or an outside institution (n = 220, 39.2%). All mpMRI images from 1026 © 2018 The Authors BJU International © 2018 BJU International outside institutions were uploaded to our Picture Archiving and Communications System (PACS; Centricity; GE Healthcare, Chicago, IL, USA). All patients underwent standardized mpMRI using 3-Tesla magnetic field strength and a pelvic phased-array coil. All MRI examinations at our institution were compliant with the American College of Radiology recommendations for technical specifications and were performed using clinical 3-Tesla MRI systems (Magnetom Skyra, Siemens Healthineers, Erlangen, Germany; Discovery MR750; GE Healthcare) equipped with either a 32-element or 18-element phased-array pelvic coil [23] . Routine sequences obtained were T1-weighted, multi-planar T2-weighted, diffusion-weighted and dynamic gadolinium contrast-enhanced MRI. The mpMRI sequences, acquisition parameters, diffusion-weighted imaging b-values used and gadolinium-based contrast agent vary between institutions, according to local protocols. At our institution, multi b-value diffusion-weighted MRI is performed using b-values ranging from b50 to b2000 and the gadolinium-based contrast agents used were gadobutrol (Gadavist, Bayer Healthcare, Leverkusen, Germany) and gadoterate meglumine (Dotarem, Guerbet). All mpMRI performed at our institution was reported by dedicated radiologists with previous experience in interpreting prostate mpMRI. Examinations performed at outside institutions were reported locally.
Pathological Examination
The prostatectomy specimen was received fresh for intraoperative consultation. The specimen was then weighed and measured. The apical aspect of the prostate was removed and serial-sectioned perpendicular to the inked margin. The tissue slices were placed in 3-cm wells on a cryostat freezing block, covered with optimum cutting temperature (Sakura Finetek Inc., Torrance, CA, USA) and topped with a cryostat chuck.
The slides were evaluated microscopically for tumour touching an inked margin. In addition to margin status (positive or negative for tumour), the location of any involved margin was reported.
Statistical Analysis
First, descriptive statistics were noted. Second, uni-and multivariable binary logistic regression analyses were performed for the outcome of interest. The receiver-operating characteristic curve curve was graphically illustrated to compute the area under the curve (AUC) for the model. A nomogram was then built based on the coefficients of the logit function. Observed vs predicted values were plotted to evaluate calibration by using the locally weighted scatter plot smoothing method.
Third, internal validation was performed using 'leave-oneout' cross-validation. The linear prediction of the logistic function, adjusted after internal validation, was used to compute the AUC of the model, to graphically assess calibration and to perform the decision curve analysis.
Fourth, in order to provide surgeons with an outline for deciding when to perform NS surgery, we performed the systematic analysis of nomogram-derived thresholds, considering the nomogram-derived probability after leaveone-out cross-validation.
Statistical analyses were performed using STATA 12 (StataCorp LP, College Station, TX, USA). All tests were two-sided with a significance level set at P < 0.05.
Results
Baseline Patient Characteristics
Descriptive characteristics for the overall population are listed in Table 1 . The median (interquartile range) age at surgery was 62 (56, 67) years and the preoperative PSA was 5.5 (4.3, 7.9) ng/mL.
The mpMRI was obtained after biopsy in 427 patients (76.1%); all the examinations were conducted at least 4 weeks Table S1 .
Study Population Characteristics
The study population consisted of 829 side-specific observations, after excluding negative biopsy observations (n = 293; Table 2 ).
Overall, ECE on final pathology was documented in 142 (17.1%) prostatic lobes, while 687 (82.9%) had organ-confined disease. The mpMRI reports documented ECE in 115 cases (14%) and organ-confined disease in 714 cases (86%). Among patients with ECE on final pathology, the mpMRI was able to correctly predict ECE in 57 cases (40.1%).
An NS approach was adopted towards 645 (77.8%) prostatic lobes, and a non-NS approach was used in 184 cases (22.2%).
Preoperative PSA, biopsy GGG, maximum percentage of core involvement and documented ECE on MRI differed significantly between the groups with and without ECE (all P ≤ 0.001). Age was not significantly different between the two groups (P = 0.06).
Uni-and Multivariable Analysis Predicting Extracapsular Extension
On univariable analyses, preoperative PSA, biopsy GGG, maximum percentage of core involvement and documented ECE on MRI emerged as predictors of ECE (all P < 0.001; Table 3 ). All of these covariates were included in the multivariable logistic regression model.
On multivariable analysis (Table 3) , preoperative PSA, biopsy GGG, and documented ECE on MRI emerged as predictors for the outcome of interest (all P ≤ 0.006). Maximum percentage of core involvement did not emerge as a predictor (P = 0.07), but was considered for the development of the nomogram given its clinical importance (Fig. 1) . The coefficients of the logit function are reported in Table S2 .
The AUC of the model was 82.92%. After performing internal validation, the AUC was 82.11%. Details concerning the AUC for mpMRI alone and the model (before and after internal validation) are shown in Table 4 . The calibration plot, exploring the relationship between observed and predicted values, before and after leave-one-out crossvalidation, is shown in Fig. 2 .
The benefit derived from applying the model in clinical practice, according to the decision curve method, is shown in Fig. 3 . The nomogram-derived probability of ECE demonstrated improved clinical risk prediction against threshold probabilities of ECE ≤25%. Moreover, the graph demonstrated better clinical risk prediction when using the nomogram if compared to relying on documented ECE vs organ-confined disease on MRI alone. Table 5 shows the systematic analysis of the nomogramderived thresholds to our data. This Table represents similarly, when applying a 17.5% and 20% threshold, 10 and nine PSMs occurred above the threshold, respectively.
Discussion
Tailoring the best surgical approach to patients in terms of NSRP represents a great challenge, as it requires a urologist to balance the risk of ECE vs the benefits of NVB preservation. The robot-assisted approach to radical prostatectomy allows the magnification of the surgical field, which some studies have shown results in lower PSM rates [24] and better functional outcomes in terms of urinary continence and erectile function [24, 25] than open radical prostatectomy; however, when ECE is highly suspected, the peri-prostatic structures, including the NVB(s) are often resected to reduce the likelihood of PSMs [2, 17] .
The aim of the present study was to produce a model for the prediction of side-specific ECE using side-specific observations. The predictors included in the model were highest biopsy GGG in the prostatic lobe, maximum percentage of core from the highest GGG core and the presence of documented ECE on mpMRI, along with preoperative PSA. Our model is therefore based on four readily available variables, which are easily applied in clinical practice, and demonstrates additional clinical benefit with respect to mpMRI findings alone, as seen in our decision curve analysis (Fig. 3) .
Unlike other authors, we did not consider prostatic lobes with no biopsy-documented tumour. Our rationale for this decision was that the prediction of side-specific ECE cannot be independent from the absence of tumour. In clinical practice, a negative biopsy does not typically result in further evaluation for ECE; therefore, a nomogram-derived probability of a negative biopsy is not of clinical utility.
By applying our nomogram, we believe that there is the potential to reduce PSMs. For example, we described the number of ECE cases (and corresponding PSMs) that occur above a 10%, 15% and 20% threshold. These would theoretically have been avoided using our nomogram because a wider excision would have been performed; however, this would come at the expense of more patients receiving NVB excision unilaterally when there was no actual ECE. In our cohort, the NS approach was chosen according to our previously published algorithm [20, 21] . This can represent a bias in the interpretation of the results in terms of PSM, however, by prospectively evaluating our data, we can potentially estimate the effect of this nomogram in its ability to reduce PSMs in future studies.
Among the models for ECE prediction, the probability table developed by Partin considers PSA, clinical stage and biopsy Gleason score [2, 18] . This model does not provide sidespecific ECE prediction, an issue which was overcome by Ohori et al. [12] , Steuber et al. [13] and Sayyid et al. [22] . In fact their nomograms consider side-specific observations for the prediction of ECE. The first achieved an AUC of 80.6%, but has not been externally validated [12] . The second achieved an AUC of 84% but this nomogram is probably limited by data skewness; for example, Gleason score 4 or 5 was protective with respect to a negative biopsy and clinical states T2c and T3 were protective with respect to T2b [13] . The last model achieved an AUC of 88% in the development cohort and 74% in the validation one [22] . The calibration used showed that the model tends to overestimate the actual probability until 40% nomogram probability of ECE. We think that this is attributable to the inclusion of operatordependent variables, such as the presence of hypoechoic nodule at TRUS and DRE findings.
With the advent of mpMRI in urology, some authors have evaluated the impact of MRI findings when added to predictive models. Augustin et al. [26] and Gupta et al. [27] have shown that mpMRI alone performs better than the Partin tables in the prediction of ECE. Feng et al. [14] have shown that adding mpMRI findings to Partin tables and to the Ohori nomogram determines a higher predictive accuracy, but those results are limited by the relatively small number of ECE cases (n = 26) with respect to the variables included in the models. Moreover they acknowledge as a limitation the fact that mpMRI was ordered when there was concern for ECE. Our series overcomes this limitation because all of our patients underwent mpMRI before surgery, thus making our results more generalizable to a community setting.
Giganti et al. [15] produced a nomogram that used apparent diffusion coefficients from mpMRI and clinical variables for side-specific ECE prediction, but they did not consider biopsy data in a side-specific manner. Their main limitation is the small number of ECE cases (n = 23) with respect to covariates. Furthermore, apparent diffusion coefficient values are dependent on the mpMRI sequence parameters used, including the choice of b-values and physiological patientrelated factors and are therefore variable [28] [29] [30] [31] [32] [33] .
We do have to acknowledge that mpMRI represents a relatively expensive tool and it is not always covered by insurance companies or by health systems based on the Beveridge model [16] . Further research is needed to evaluate the ability of mpMRI to reduce PSMs and the potential cost benefit this could subsequently provide by potentially reducing the need for adjuvant therapy secondary to PSMs.
The present study has several strengths. First, we have a large sample size and number of events (ECE). Second, all surgeries were performed by a single urologist. Third, all patients underwent mpMRI before surgery, thus avoiding a sampling bias. Furthermore, in an effort to lower the operatordependent variability, we only considered mpMRI reports that documented definite ECE while considering other terminology (see Methods) as negative. Eventually we have shown that by applying our nomogram, we could potentially achieve a reduction in our PSM rate among T3 disease; we have started using the nomogram-derived probability prospectively to evaluate long-term effect(s) and outcomes.
The study also has some limitations. First, we did not conduct a centralized retrospective review of mpMRI images for PCa detection, characterization and assessment for the probability for ECE. This limitation, however, is more reflective of daily clinical practice and does not represent a limitation sensu stricto; rather, it guarantees generalization of our model. Second, 17.5% of our biopsies were targeted. Again, this limitation can allow generalization of our model as well, as targeted biopsy along with systematic sampling are not performed by everybody in day-to-day practice; it is noteworthy that by increasing the number of targeted biopsies the accuracy of the model would reliably increase. Lastly, this study is the result of a single tertiary centre experience and therefore needs to be validated by external data.
In conclusion, we have developed an easy-to-use model for the prediction of side-specific ECE that uses for variables from preoperative and mpMRI data. The nomogram-derived probability can serve as an aid when deciding whether to perform NS in patients with optimal pre-surgical erectile function. By applying the nomogram-derived probability to our data, using a 20% threshold, nine PSMs resulted above the threshold; by applying this model we can potentially reduce our PSMs in future series.
